---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-263541"
form_type: "8-K"
ticker: "STIM"
cik: "0001227636"
company_name: "Neuronetics, Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:33:29.409932+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Neuronetics Q3 revenue $37.3M (+11% adj pro forma); FY guidance cut; CEO Sullivan to retire June 2026

## Summary
- Revenue $37.3M (+101% YoY, +11% adjusted pro forma); Greenbrook clinic revenue $21.8M (+25% adj pro forma).
- Net loss $(9.4)M ($0.13/shr) vs $(13.3)M ($0.44/shr) last year; gross margin 45.9% (down from 75.6% on business mix).
- Lowers FY2025 revenue guidance to $147-150M (from $149-155M); gross margin 47-49% (from 48-50%).
- CEO Keith Sullivan to retire June 30, 2026; board commenced search; no dispute with management.
- Ended Q3 with $34.5M cash; used $0.8M in ops; secured additional $10M Perceptive debt; raised $7.8M net via ATM.

## SEC filing metadata
- accession: 0001193125-25-263541
- form_type: 8-K
- ticker: STIM
- cik: 0001227636
- company_name: Neuronetics, Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1227636/000119312525263541/0001193125-25-263541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1227636/000119312525263541/d98237d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-263541
- JSON: https://secwatch.observer/filing/0001193125-25-263541.json
- Plain text: https://secwatch.observer/filing/0001193125-25-263541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.